Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Maravai Lifesciences Holdings (MRVI) FCF Payout Ratio (2020 - 2024)

Maravai Lifesciences Holdings (MRVI) has 5 years of FCF Payout Ratio data on record, last reported at 0.0 in Q4 2024.

  • For Q4 2024, FCF Payout Ratio changed N/A year-over-year to 0.0; the TTM value through Sep 2025 reached 0.01, down 111.04%, while the annual FY2024 figure was 0.02, 114.06% down from the prior year.
  • FCF Payout Ratio reached 0.0 in Q4 2024 per MRVI's latest filing, down from 0.11 in the prior quarter.
  • Across five years, FCF Payout Ratio topped out at 1.17 in Q4 2020 and bottomed at 0.0 in Q4 2024.
  • Average FCF Payout Ratio over 5 years is 0.31, with a median of 0.25 recorded in 2022.
  • Peak YoY movement for FCF Payout Ratio: soared 19455.66% in 2021, then plummeted 79.62% in 2023.
  • A 5-year view of FCF Payout Ratio shows it stood at 1.17 in 2020, then crashed by 38.8% to 0.72 in 2021, then crashed by 48.68% to 0.37 in 2022, then plummeted by 85.4% to 0.05 in 2023, then plummeted by 96.58% to 0.0 in 2024.
  • Per Business Quant database, its latest 3 readings for FCF Payout Ratio were 0.0 in Q4 2024, 0.11 in Q2 2024, and 0.05 in Q2 2023.